Speakers

Dr Katie Snape is Principal Clinician at Genomics England supporting development of a translational research programme for the adult population to generate evidence and digital infrastructure to assess the impact of pre-emptive genomic testing.  Katie is a Consultant in Cancer Genetics at the South West Thames Centre for Genomics and Retiring Chair of the UK Cancer Genetics Group, a national organisation to improve the assessment and management of people with enhanced genetic cancer risk.

Katie has a PhD in molecular genetics from the Institute of Cancer Research. Her PhD involved using next generation sequencing technologies to identify cancer associated genomic variation. Katie has a Postgraduate Certificate in Healthcare and Biomedical Education, is a Fellow of the Higher Education Academy and a Reader at City, St George’s University of London. Katie specialises in germline predisposition to haematological malignancies working in the Haematology Medicine service at Kings College Hospital.